You've been lied to about Ozempic. These are the 6 biggest lies.

Business Insider spent months digging into the research and the discourse. What they found: the hype is wrong, the fear is wrong, and the truth is messier than either side admits.

You're Being Lied To About Ozempic | Truth Complex | Business Insider

You'll see it in comments, in TikToks, in the skeptical question someone asks at dinner: these drugs are brand new, untested, not studied for weight loss in people without diabetes.

None of that is true. GLP-1 receptor agonists have been used for decades to treat type 2 diabetes. Semaglutide, the active ingredient in Ozempic and Wegovy, has been studied in thousands of people specifically for obesity, not diabetes. The new part is that Ozempic became a household name. The drug itself is not new.

What is worth unpacking, Business Insider notes, is that none of these diabetes treatments became famous until they started making celebrities skinny. A million and a half people die of diabetes each year, but it took weight loss to make anyone pay attention.

Our society is so weight-obsessed that none of these diabetes treatments were a household name even though a million and a half people die of it each year, but as soon as it started making celebrities skinny, all of us were talking about it.Business Insider

2. '86% effective' means 14% of people get nothing

The early trials were remarkable. People on semaglutide lost an average of 15% of their body weight when paired with diet and exercise, compared to 2.4% for people just dieting and exercising. Tirzepatide did even better: 20% average weight loss.

But roughly one in 10 people are nonresponders. They don't lose significant weight at all.

Business Insider found Erika, a woman whose doctor never warned her the drug might not work for her. Most of her information came from media coverage that framed GLP-1s as miracle drugs. When you set them up that way, you set people up for massive disappointment if the drug fails them.

Then there's the gap between clinical trials and real life. A 2023 study followed people on semaglutide for 52 weeks. They lost an average of 4.4% of their body weight. Not 15%. That's a dramatic difference, and it hasn't gotten nearly the same press coverage.

I'm mad it didn't work, but then it just, I accept it, and I just got to find another way to lose the weight.Business Insider

Why this matters if you haven’t started yet: If you're starting a GLP-1 based on trial results you saw in the news, know that real-world results are lower and that some people, about 10%, won't respond at all.

3. Weight loss plateaus, and most people quit anyway

Every weight loss intervention plateaus: diet, exercise, bariatric surgery, and GLP-1 drugs. At some point, you stop losing. That's not a failure of the drug. It's biology.

You wouldn't want a drug that lets you lose unlimited weight. That would be dangerous, and you'd have to stop eventually, which would trigger regain and turn into constant yo-yoing.

But people talk about the plateau like it's a betrayal. And they stop taking the drug. One study found that about half of people with GLP-1 prescriptions stopped after a year. Seventy percent stopped by two years.

When they stop, they regain weight. On average, people regained two-thirds of what they'd lost.

Why this matters if you haven’t started yet: All evidence points to needing to keep taking these drugs to keep benefiting from them. If you're not willing to stay on long term, the impact will be much lower than you expect.

4. Big Pharma is cashing in, and 'nature's Ozempic' won't save you

Yes, Novo Nordisk will make a ton of money. At one point, the company's valuation was bigger than the entire GDP of Denmark. The cynic in all of us wakes up when we hear these are potentially lifelong medications.

Novo Nordisk has paid fines for shady sales tactics, faced criticism for wining and dining doctors, and gotten in trouble for high insulin prices. The distrust is not irrational.

That distrust has pushed people toward berberine, peppermint tea, green tea, vitamin B12, high-fiber diets, all pitched as natural alternatives to Ozempic. Some foods do increase the GLP-1 hormone your body makes. But the level of GLP-1 from diet is nowhere near what you get from a prescription drug.

These are orders of magnitude different, a researcher told Business Insider. You're not going to see anywhere near the same effects. The foods and vitamins are generally less risky than a serious prescription drug, but they're almost definitely less effective too.

These interventions are leading to supraphysiological levels of GLP-1, as opposed to modest changes in your diet or some supplement that you could take.Business Insider

5. The side effects are real, but so is the scaremongering

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea. They sound trivial, but extended vomiting or diarrhea can leave you dangerously dehydrated. One woman died while taking these drugs after months of severe vomiting and abdominal pain.

The FDA label includes a black-box warning about thyroid C-cell tumors, based on findings in rodents. But a GLP-1 researcher told Business Insider that the thyroid in rodents and humans is quite different, so those findings probably aren't relevant. Meanwhile, the link between obesity and thyroid cancer is much clearer: for every five-point increase in BMI, the risk of thyroid cancer increases by 30%.

The label also lists warnings for acute pancreatitis, acute gallbladder disease, hypoglycemia, acute kidney injury, heart-rate increase, and suicidal behavior and ideation. That last one is especially unsettling, though the weight of evidence so far suggests the drugs alone don't cause suicidal thoughts.

Most of the more serious side effects are rare. Most people who take these medications will not get pancreatitis. It's not uncommon for drugs to have intimidating FDA warning labels. Metformin, a popular diabetes medication, has a warning for potentially fatal lactic acidosis. Ibuprofen has a warning about increased risk of stroke.

Then there's the cosmetic stuff: Ozempic face, hair loss, muscle loss. But whenever you lose weight, even through diet and exercise, you tend to lose some lean muscle. Rapid weight loss through diet alone has been linked to hair loss, muscle loss, depression, and gallstones, all side effects that overlap with Ozempic. It's hard to tell where one ends and the other begins.

Business Insider put it bluntly: people seem to want there to be a punishment for taking a vanity drug and almost gleefully report the idea that your face or your hair would fail you when you've taken a step to make your body look nicer.

Why this matters if you haven’t started yet: If you take these drugs and don't have a medical need for them, your risk calculation is different and you are putting yourself at greater risk of harm.

6. Compounded semaglutide is a gamble, and no one knows how big

The explosion of interest in semaglutide put the drug in shortage. When drugs are on the official FDA shortage list, compounding pharmacies can make their own versions. Compounded versions are not FDA-approved or reviewed, and because these pharmacies are regulated at the state level, there's no data for how many people are taking compounded GLP-1s.

One researcher purposefully ordered compounded semaglutide from shady online sellers to see what he would get. Of the six orders, three never came at all. Total scams. Of the three that did arrive, tests found evidence of contamination and improper amounts of semaglutide. The FDA has also warned about some compounders using semaglutide salt, which is generally used only for research and is not approved for use in humans.

Business Insider went through the process of being prescribed compounded semaglutide through an online pharmacy. All it took was a survey and a video telehealth visit. From the second the call started, it was a given that the prescription would be written. The doctor didn't mention that the patient would need to stay on the drug to maintain weight loss.

The upside: for some people, compounding pharmacies offer a cheaper version. Business Insider paid $250 for a month's supply. The list price for Ozempic is almost $1,000. For Wegovy, it's $1,349.

When you source it from a no-prescription online pharmacy, there's a lot of risks. Either fraud, incorrect product, or you're not getting a product that is medically necessary for you or appropriate for you.Business Insider

Why this matters if you haven’t started yet: Compounded semaglutide comes with a higher degree of risk. If you're considering it, know that you're trading some safety and oversight for cost.

The biggest lie isn't about the drug. It's about weight loss itself. For decades, the message has been that all it takes is small tweaks: swap chips for an apple, take the stairs. That advice is bizarre given what we know now. When you lose weight, your body releases hormones that increase appetite and reduce fullness. If you lose roughly 20 pounds and maintain it, you're burning about 250 calories per day less than before you lost the weight. Your body fights back.

Studies combining diet, exercise, and behavioral counseling show people tend to lose only 5% to 10% of their body weight. Drastic weight loss is exceedingly rare and usually temporary. Some people say GLP-1s are a Band-Aid on bigger systemic problems: our food system, our sedentary lifestyles. Maybe. But for now, we have a relatively safe and effective drug that gives people another tool to manage their health in the meantime. Sometimes you just need a Band-Aid.

Questions people ask

Are GLP-1 drugs like Ozempic untested or not well studied?

No. GLP-1 receptor agonists have been used for decades to treat type 2 diabetes, and semaglutide has been studied in thousands of people specifically for obesity, not diabetes. The drugs themselves are not new, just the household-name status.

Do GLP-1 drugs work for everyone?

No. Roughly one in 10 people are nonresponders and don't lose significant weight on semaglutide or tirzepatide. Real-world studies also show much lower average weight loss (4.4%) than the clinical trials (15%).

Is compounded semaglutide safe?

Compounded semaglutide is not FDA-approved or reviewed and comes with higher risk. One researcher found that half the orders he placed online never arrived, and the ones that did showed evidence of contamination or incorrect dosing. If you're considering it, know you're trading safety and oversight for lower cost.

BI
Business Insider

Business Insider is a US publication that investigated GLP-1 medications, including going through the prescription process for compounded semaglutide and interviewing researchers, patients, and clinicians. 1,563,779 views on the original video.

Watch the original on YouTube →

Trending Topics

Free, from GLP‑1 Classified

Thinking about a GLP‑1? Read our guide before you start.

The questions to ask, the costs nobody mentions, and what the first month really feels like. Plus a short weekly letter for people on, or considering, a GLP‑1. We are not a pharmacy or a telehealth brand. We work for you, not for them.

No spam. Unsubscribe any time.